Semaglutide was first introduced to the market under the brand name Ozempic, primarily as a treatment for type 2 diabetes
Acute Fat Oxidation and Energy Expenditure Acute single administration of AOD9604 in wild-type mice produced a significant increase in fat oxidation and energy expenditure, with an associated reduction in glucose oxidation
Product Facts Supplement Facts Serving Size 2 Liquid Soft-Gels Servings Per Container 30 **%Percent Daily Values are based on a 2,000 calorie dietDaily Value not established Other Ingredients: Gelatin, purified water, glycerin, maltodextrin, vegetable gum, sunflower lecithin, beeswax, annatto (color), titanium dioxide (color), St
Active malignancy is a contraindication because NAD+ supports cellular proliferation
Semaglutide is a GLP-1 receptor agonist